CAPTRUST Financial Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,468
| Closed | -$543K | – | 2450 |
|
|
2024
Q4 | $543K | Buy |
4,468
+597
| +15% | +$72.6K | ﹤0.01% | 1564 |
|
|
2024
Q3 | $483K | Buy |
3,871
+511
| +15% | +$63.8K | ﹤0.01% | 1591 |
|
|
2024
Q2 | $531K | Buy |
3,360
+938
| +39% | +$148K | ﹤0.01% | 1469 |
|
|
2024
Q1 | $314K | Sell |
2,422
-2,448
| -50% | -$317K | ﹤0.01% | 1750 |
|
|
2023
Q4 | $470K | Sell |
4,870
-793
| -14% | -$76.5K | ﹤0.01% | 1777 |
|
|
2023
Q3 | $686K | Sell |
5,663
-235
| -4% | -$28.5K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $675K | Sell |
5,898
-826
| -12% | -$94.6K | ﹤0.01% | 1455 |
|
|
2023
Q1 | $927K | Buy |
6,724
+783
| +13% | +$108K | ﹤0.01% | 1082 |
|
|
2022
Q4 | $770K | Buy |
5,941
+2,153
| +57% | +$279K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $419K | Buy |
3,788
+317
| +9% | +$35.1K | ﹤0.01% | 1331 |
|
|
2022
Q2 | $260K | Buy |
3,471
+44
| +1% | +$3.3K | ﹤0.01% | 1511 |
|
|
2022
Q1 | $268K | Buy |
3,427
+77
| +2% | +$6.02K | ﹤0.01% | 1523 |
|
|
2021
Q4 | $302K | Sell |
3,350
-2,627
| -44% | -$237K | ﹤0.01% | 1381 |
|
|
2021
Q3 | $553K | Sell |
5,977
-665
| -10% | -$61.5K | ﹤0.01% | 989 |
|
|
2021
Q2 | $516K | Sell |
6,642
-101
| -1% | -$7.85K | ﹤0.01% | 975 |
|
|
2021
Q1 | $503K | Sell |
6,743
-142
| -2% | -$10.6K | 0.01% | 949 |
|
|
2020
Q4 | $1.17M | Sell |
6,885
-70
| -1% | -$11.9K | 0.02% | 567 |
|
|
2020
Q3 | $984K | Sell |
6,955
-215
| -3% | -$30.4K | 0.02% | 516 |
|
|
2020
Q2 | $1.19M | Sell |
7,170
-4,145
| -37% | -$687K | 0.02% | 454 |
|
|
2020
Q1 | $1.05M | Sell |
11,315
-765
| -6% | -$71.1K | 0.02% | 408 |
|
|
2019
Q4 | $1.56M | Buy |
+12,080
| New | +$1.56M | 0.02% | 417 |
|